A single-center experience of the use of interleukin-2 receptor antagonists for various situations in liver transplant recipients

Transplantation Proceedings

Volumn 46, Issue 3, 2014, Pages 739-743

  Togashi, J ^a,c   Sugawara, Y ^a   Akamatsu, N ^a   Tamura, S ^a   Tanaka, T ^b   Kaneko, J ^a   Aoki, T ^a   Sakamoto, Y ^a   Hasegawa, K ^a   Kokudo, N ^a  

^a University of Tokyo   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOKYO ROSAI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CALCINEURIN INHIBITOR; CYCLOSPORIN; METHYLPREDNISOLONE; RITUXIMAB; TACROLIMUS; HYBRID PROTEIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR; MONOCLONAL ANTIBODY;

ADULT; BLOOD GROUP TYPING; BRAIN DISEASE; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTIOUS COMPLICATION; KIDNEY FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LYMPHOCYTOTOXICITY; MALE; MIDDLE AGED; PRIORITY JOURNAL; THROMBOTIC THROMBOCYTOPENIC PURPURA; YOUNG ADULT; ADOLESCENT; ANTAGONISTS AND INHIBITORS; COHORT ANALYSIS;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; COHORT STUDIES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2; RECOMBINANT FUSION PROTEINS; YOUNG ADULT;

EID: 84899517487     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2013.11.075     Document Type: Conference Paper

References (22)

1. A.P. Turner, and S.J. Knechtle Induction immunosuppression in liver transplantation: a review Transplant Int 26 7 2013 673 683
2. M.L. Weber, H.N. Ibrahim, and J.R. Lake Renal dysfunction in liver transplant recipients: evaluation of the critical issues Liver Transplant 18 11 2012 1290 1301
3. M. Campara, I.G. Tzvetanov, and J. Oberholzer Interleukin-2 receptor blockade with humanized monoclonal antibody for solid organ transplantation Expert Opinion Biological Therapy 10 6 2010 959 969
4. L. Rostaing, F. Saliba, and Y. Calmus et al. Review article: use of induction therapy in liver transplantation Transplant Rev 26 4 2012 246 260
5. Y. Sugawara, M. Makuuchi, and J. Kaneko et al. Correlation between optimal tacrolimus doses and the graft weight in living donor liver transplantation Clin Transplant 16 2 2002 102 106
6. M. Berenguer, M. Prieto, and J. Cordoba et al. Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: association with treatment of rejection J Hepatol 28 5 1998 756 763
7. N. Akamatsu, Y. Sugawara, and J. Kaneko et al. Risk factors of cytomegalovirus infection after living donor liver transplantation Hepatogastroenterology 52 61 2005 197 199
8. N. Akamatsu, Y. Sugawara, and J. Kaneko et al. Preemptive treatment of fungal infection based on plasma (1-> 3)beta-D-glucan levels after liver transplantation Infection 35 5 2007 346 351
9. M. Hashimoto, Y. Sugawara, and S. Tamura et al. Bloodstream infection after living donor liver transplantation Scand J Infect Dis 40 6-7 2008 509 516
10. S. Gruttadauria, L. Mandala, and D. Biondo et al. Role of basiliximab in the prevention of acute cellular rejection in adult to adult living-related liver transplantation: a single center experience Biologics Targets Therapy 1 1 2007 69 73
11. C.C. Lin, F.R. Chuang, and C.H. Lee et al. The renal-sparing efficacy of basiliximab in adult living donor liver transplantation Liver Transplant 11 10 2005 1258 1264
12. N. Arora, P.J. McKiernan, and S.V. Beath et al. Concomitant basiliximab with low-dose calcineurin inhibitors in children post-liver transplantation Pediatr Transplant 6 3 2002 214 218
13. Y.K. Kim, K.W. Lee, and S.H. Kim et al. Early steroid withdrawal regimen prevents new-onset diabetes mellitus in old-age recipients after living donor liver transplantation World J Surg 36 10 2012 2443 2448
14. N. Kamar, J.S. Borde, and K. Sandres-Saune et al. Induction therapy with either anti-CD25 monoclonal antibodies or rabbit antithymocyte globulins in liver transplantation for hepatitis C Clin Transplant 19 1 2005 83 89
15. A.D. Goralczyk, N. Hauke, and N. Bari et al. Interleukin 2 receptor antagonists for liver transplant recipients: a systematic review and meta-analysis of controlled studies Hepatology 54 2 2011 541 554
16. T. Aoki, Y. Sugawara, and M. Takahashi et al. Living donor liver transplantation using sensitized lymphocytotoxic crossmatch positive graft J Gastroenterol 47 4 2012 486 488
17. D.W. Orr, B.C. Portmann, and A.S. Knisely et al. Anti-interleukin 2 receptor antibodies and mycophenolate mofetil for treatment of steroid-resistant rejection in adult liver transplantation Transplant Proc 37 10 2005 4373 4379
18. M.M. Aw, R.M. Taylor, and A. Verma et al. Basiliximab (Simulect) for the treatment of steroid-resistant rejection in pediatric liver transpland recipients: a preliminary experience Transplantation 75 6 2003 796 799
19. M.L. Fernandes, Y.M. Lee, and D. Sutedja et al. Treatment of steroid-resistant acute liver transplant rejection with basiliximab Transplant Proc 37 5 2005 2179 2180
20. Y. Nakazawa, Y. Hashikura, and K. Urata et al. Von Willebrand factor-cleaving protease activity in thrombotic microangiopathy after living donor liver transplantation: a case report Liver Transplant 9 12 2003 1328 1333
21. N. Akamatsu, Y. Sugawara, and S. Tamura et al. Late mortality from thrombotic microangiopathy after liver transplantation: report of a case Surg Today 37 4 2007 345 348
22. P.W. Shepard, and E.K. St Louis Seizure treatment in transplant patients Current Treatment Options Neurol 14 4 2012 332 347